Abstract
Glycosphingolipids in cerebrospinal fluid (CSF) of individual patients with multiple sclerosis (MS) were analyzed using a glycolipid-overlay technique. The ganglioside composition of CSF of non-MS patients was characterized by an abundance of polysialo species, including GT1b and GQ1b. This pattern is completely different from that of human white or gray matter, in which mono- and disialogangliosides predominate. Increased levels of GM1, either associated with or without increases of other gangliosides, such as GD1a, were observed in 16% of the patients with MS (6 of 37 cases: 1 of 15 progressive progressive stage, 4 of 16 progressive stationary stage, and 1 of 6 relapsing stage). The concentration of GD3 was increased in 23% (3 of 13 cases), whereas 1 of 13 cases (8%) showed a dramatic increase of sulfoglucuronyl paragloboside (SGPG) associated with a high level of GD3. These changes may reflect the cellular changes associated with the known pathological lesions in MS, which are characterized by demyelination, gliosis, and/or remyelination with oligodendrocytic proliferation.
References
Sep 1, 1978·Analytical Biochemistry·S AndoR K Yu
Feb 1, 1979·Journal of Neurochemistry·R K Yu, K Iqbal
Dec 23, 1976·The New England Journal of Medicine·S R CohenG M McKhann
Aug 1, 1990·Journal of Neurochemistry·N MiyataniR K Yu
May 1, 1987·Journal of Neurochemistry·T KohriyamaR K Yu
Jan 1, 1989·Clinical Immunology and Immunopathology·H F McFarland, S Dhib-Jalbut
Nov 24, 1989·Journal of Chromatography·P DavidssonL Svennerholm
Sep 1, 1988·Analytical Biochemistry·G S Wu, R Ledeen
Aug 2, 1986·Journal of Chromatography·J Portoukalian, B Bouchon
Sep 1, 1973·Neurology·Y NagaiW W Tourtellotte
Oct 1, 1973·Journal of Neurochemistry·R W LedeenL F Eng
Mar 1, 1970·Journal of the Neurological Sciences·W Tourtellotte
Jan 1, 1984·Annals of the New York Academy of Sciences·J N Whitaker
Jan 1, 1984·Annals of the New York Academy of Sciences·R P LisakD H Silberberg
Dec 1, 1984·Journal of Neuroimmunology·J E GoldmanT N Seyfried
Jan 1, 1984·Annals of the New York Academy of Sciences·W W TourtellotteP Shapshak
Oct 1, 1984·Journal of Neurochemistry·I KraĉunA Stavljenić
Jan 1, 1984·Annals of the New York Academy of Sciences·J W PrineasL R Sharer
Jan 1, 1984·Advances in Experimental Medicine and Biology·T N Seyfried, R K Yu
Apr 1, 1982·The Journal of Experimental Medicine·C S PukelL J Old
Aug 1, 1982·Journal of Neurochemistry·R K YuW W Tourtellotte
Citations
Aug 1, 1995·Journal of the Neurological Sciences·A MatsumotoT Miyatake
Dec 1, 1988·Journal of Neuroimmunology·W W TourtellotteI Rosario
Oct 1, 1994·Journal of Neuroimmunology·A J ConradW W Tourtellotte
Feb 1, 1989·Research in Immunology·H LinkT Olsson
Jun 1, 2000·Journal of the Neurological Sciences·G RaknesC A Vedeler
Jan 18, 2003·Biochimica Et Biophysica Acta·Florence Malisan, Roberto Testi
Jul 1, 1994·The Journal of Cell Biology·T KandaR K Yu
Nov 1, 1992·Journal of Neurochemistry·H YoshinoR K Yu
Oct 10, 2006·Veterinary Immunology and Immunopathology·R J MilnerJ Farese
Apr 17, 2016·Progress in Neurobiology·Pejman Rahimian, Johnny J He
Dec 7, 2013·Multiple Sclerosis International·Judith M Greer
Jun 12, 2002·Cell Death and Differentiation·B M SimonM Leist
Jan 1, 1992·Journal of Neurochemistry·M Saito, R K Yu
May 2, 2009·Journal of Leukocyte Biology·Kwang Soo KimSang Myun Park
Aug 27, 2019·Frontiers in Neurology·Pierre J MagistrettiSimonetta Sipione
Jun 20, 2001·Chemistry : a European Journal·J C Castro-PalominoR R Schmidt
Oct 30, 2020·Frontiers in Neuroscience·Simonetta SipioneVaibhavi Kadam
May 18, 2021·Frontiers in Pharmacology·Charles FinsterwaldSylvain Lengacher